Diagnostic services for onco prostate testing
Ended Blanket Purchase Agreement Awarded Last action
- Contract number
- HT001421A0031
- Awardee
-
Genomic Health, Inc. UEI RHN3L7SBF7J6 Part of Exact Sciences Corporation
- Awarding agency
-
Defense Health Agency
Department of Defense
- Task orders
- 3 $435,199 obligated
Award facts
- Combined order value
- $435,199 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 9% used
- $5,000,000.00
- Maximum order
- $300,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Health Agency awarded a single-award blanket purchase agreement to Genomic Health, Inc., a division of Exact Sciences Corporation, for diagnostic services for oncology prostate testing. The potential value of the agreement is $5,000,000 to be utilized over four years through individual task order calls. The agreement aims to support the Agency's efforts to advance cancer screening and personalized treatment selection through Genomic Health's Oncotype Portfolio of genomic tests for earlier cancer detection and cancer treatment.
A task order call against the blanket purchase agreement was awarded to Genomic Health, Inc. for $145,066.32 to deliver the Oncotype Portfolio genomic tests. Performance will take place in Bethesda, Maryland over one year under a firm fixed price arrangement. The task order aims to advance cancer screening and personalized treatment selection at the Defense Health Agency through Genomic Health's genomic tests for earlier cancer detection and cancer treatment selection. No subcontractors or socioeconomic set-asides were identified for this task order.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Oncotype IQ genomic testing | Defense Health Agency | $145,066 | |
| Oncotype portfolio of genomic tests to provide patient care support in anatomic pathology | Defense Health Agency | $145,066 | |
| Oncotype portfolio of genomic tests for earlier cancer detection and cancer treatment. | Defense Health Agency | $145,066 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HT001421A0031?
HT001421A0031 was awarded to Genomic Health, Inc. by Defense Health Agency (Department of Defense) on September 30, 2021.
How much is contract HT001421A0031 worth?
Orders under HT001421A0031 have obligated $435,199. HT001421A0031's own ceiling is $5,000,000. A single order can be worth up to $300,000.
How many orders have been placed under contract HT001421A0031?
3 orders have been placed under HT001421A0031, the latest on September 8, 2025.
Who can order from contract HT001421A0031?
HT001421A0031 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV